Inventor
PALACKAL NISHA
US17 patents
⚠️ This page may combine multiple inventors who share the name “PALACKAL NISHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
16 patentsUS11459374B2Oct 4, 2022
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA13 citations97
US11174283B2Nov 16, 2021
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA13 citations97
US11053280B2Jul 6, 2021
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA19 citations97
US11459373B2Oct 4, 2022
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA8 citations94
US11299532B2Apr 12, 2022
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA8 citations94
US12049489B2Jul 30, 2024
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA2 citations84
US11649273B2May 16, 2023
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA2 citations84
US11407813B2Aug 9, 2022
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA3 citations84
US11286290B2Mar 29, 2022
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA1 citations84
US11180540B2Nov 23, 2021
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA2 citations84
US11098112B2Aug 24, 2021
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA1 citations84
US11505594B2Nov 22, 2022
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA1 citations83
US12202883B2Jan 21, 2025
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA0 citations73
US12077570B2Sep 3, 2024
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA0 citations73
US12054533B2Aug 6, 2024
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA0 citations73
US11782023B2Oct 10, 2023
Ce-western applications for antibody development
REGENERON PHARMA0 citations57